MISSION STATEMENT
Through international partnerships, Terasaki Innovation Center, Inc. (TIC) will facilitate discovery and development of new pathways and tools needed to diagnose and manage allograft rejection.
OUR PURPOSE
Driven by the legacy of Dr. Paul Terasaki and his vision for improving the lives of transplant patients worldwide, Terasaki Innovation Center, Inc. (TIC) will continue his quest for discoveries and innovations that will lead to a better understanding of the mechanism of allograft rejection. The overall goal of Terasaki Innovation Center, Inc. (TIC) is to support transplant clinicians and their patients via global collaborations.
Directors & Officers
.jpg)
Ricardo Ordoñez
President
Former Sr. Director of Marketing
& Customer Experience
One Lambda, A Thermo Fisher Scientific Brand
Los Angeles, California
Jar How Lee, Ph.D
Chief Scientific Officer
Treasurer/Board Member
Former Chief Scientific Officer
One Lambda, A Thermo Fisher Scientific Brand
Los Angeles, California
Mayra Lopez-Cepero, Ph.D.
Secretary
Senior Vice President and Director
Transplant Immunology Lab
LifeLink Foundation
Tampa, Florida
Peter Nickerson, MD
Board Member
Vice-Dean (Research) and Distinguished Professor
Medical Director, Transplant Manitoba University of Manitoba
Winnipeg, Canada
Robert Bray, Ph.D
Board Member
Co-Director, Histocompatibility & Molecular Immunogenetics Laboratory
Emory University Hospital
Atlanta, Georgia
Cathi Murphey, Ph.D.
Board Member
President/COO
Southwest Immunodiagnostics
San Antonio, Texas
Mark Terasaki, Ph.D
Chairman of the Board
Associate Professor
Department of Cell Biology
University of Connecticut Health Center
Farmington, Connecticut